Annual Report Novo Nordisk 2024. The meeting will be held. 24256790 our medicines are for the approved indication for which they are authorised in the local country or region.
In many ways, 2023 has been a transformational year where we made significant progress on our novo nordisk pharmatech growth strategy. Novo nordisk global business services address: